Related references
Note: Only part of the references are listed.Icariside II, a novel phosphodiesterase 5 inhibitor, protects against H2O2-induced PC12 cells death by inhibiting mitochondria-mediated autophagy
Jianmei Gao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer's Disease
Yura Choi et al.
MOLECULAR NEUROBIOLOGY (2017)
Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell
Qipeng Xie et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells
Guoqiong Cao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease
Jose Antonio Allue et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease
Wenzhong Yang et al.
NEUROBIOLOGY OF AGING (2016)
Icariside II protects against cerebral ischemia-reperfusion injury in rats via nuclear factor-κB inhibition and peroxisome proliferator-activated receptor up-regulation
Yuanyuan Deng et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms
Ying Du et al.
NEUROPHARMACOLOGY (2016)
ICARISIDE II, A NOVEL PHOSPHODIESTERASE-5 INHIBITOR, ATTENUATES STREPTOZOTOCIN-INDUCED COGNITIVE DEFICITS IN RATS
Caixia Yin et al.
NEUROSCIENCE (2016)
GASTRODIN SUPPRESSES BACE1 EXPRESSION UNDER OXIDATIVE STRESS CONDITION VIA INHIBITION OF THE PKR/eIF2α PATHWAY IN ALZHEIMER'S DISEASE
J. -S. Zhang et al.
NEUROSCIENCE (2016)
APP Is a Context-Sensitive Regulator of the Hippocampal Presynaptic Active Zone
Melanie Lassek et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
Urmi Sengupta et al.
EBIOMEDICINE (2016)
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Osama Sabri et al.
ALZHEIMERS & DEMENTIA (2015)
Alzheimer's Association Report 2015 Alzheimer's disease facts and figures
ALZHEIMERS & DEMENTIA (2015)
Sodium Hydrosulfide Attenuates Beta-Amyloid-Induced Cognitive Deficits and Neuroinflammation via Modulation of MAPK/NF-κB Pathway in Rats
Huiyu Liu et al.
CURRENT ALZHEIMER RESEARCH (2015)
A review of biotransformation and pharmacology of ginsenoside compound K
Xi-Ding Yang et al.
FITOTERAPIA (2015)
Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPARγ
S. Strobel et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Increased Alzheimer's disease-like pathology in the APP/PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy
Gururaj Joshi et al.
NEUROBIOLOGY OF AGING (2015)
ICARIIN DECREASES BOTH APP AND Aβ LEVELS AND INCREASES NEUROGENESIS IN THE BRAIN OF Tg2576 MICE
F. Li et al.
NEUROSCIENCE (2015)
PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
Anindita Das et al.
PHARMACOLOGY & THERAPEUTICS (2015)
DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice
Ran-Yao Yang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain
Paul Saftig et al.
PROGRESS IN NEUROBIOLOGY (2015)
β-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease
Xiaojuan Sun et al.
FRONTIERS IN PHARMACOLOGY (2015)
Icariside II improves cerebral microcirculatory disturbance and alleviates hippocampal injury in gerbils after ischemia-reperfusion
Ben-Yong Yan et al.
BRAIN RESEARCH (2014)
Icariin, a phoshphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling
Feng Jin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects
Robert Vassar et al.
JOURNAL OF NEUROCHEMISTRY (2014)
PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease
Latha Devi et al.
NEUROBIOLOGY OF AGING (2014)
Hydrogen sulfide improves spatial memory impairment and decreases a production of Aβ in APP/PS1 transgenic mice
Xuan-li He et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand et al.
NEUROPHARMACOLOGY (2014)
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement
Caterina Scuderi et al.
PHYTOTHERAPY RESEARCH (2014)
Genetic mouse models of brain ageing and Alzheimer's disease
Andras Bilkei-Gorzo
PHARMACOLOGY & THERAPEUTICS (2014)
Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer's disease
Ling-Yun Fan et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
Natalia N. Nalivaeva et al.
Frontiers in Aging Neuroscience (2014)
Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria
Maria C. Carrillo et al.
ALZHEIMERS & DEMENTIA (2013)
Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice
Junfang Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Denervation of the Olfactory Bulb Leads to Decreased Aβ Plaque Load in a Transgenic Mouse Model of Alzheimer's Disease
Olivier Bibari et al.
CURRENT ALZHEIMER RESEARCH (2013)
Arctigenin Effectively Ameliorates Memory Impairment in Alzheimer's Disease Model Mice Targeting Both β-Amyloid Production and Clearance
Zhiyuan Zhu et al.
JOURNAL OF NEUROSCIENCE (2013)
ADAM10 Prodomain Mutations Cause Late-Onset Alzheimer's Disease: Not Just the Latest FAD
Robert Vassar
NEURON (2013)
Deletion of the eIF2α Kinase GCN2 Fails to Rescue the Memory Decline Associated with Alzheimer's Disease
Latha Devi et al.
PLOS ONE (2013)
Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome
Antero Salminen et al.
PROGRESS IN NEUROBIOLOGY (2013)
The role of APP and BACE1 trafficking in APP processing and amyloid-beta generation
Xiaojie Zhang et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Aβ Secretion and Plaque Formation Depend on Autophagy
Per Nilsson et al.
CELL REPORTS (2013)
Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease
Ana Garcia-Osta et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Neuronal β-amyloid generation is independent of lipid raft association of β-secretase BACE1: analysis with a palmitoylation-deficient mutant
Kazumi Motoki et al.
BRAIN AND BEHAVIOR (2012)
Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease
Wei Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Modulation of Tau Phosphorylation by the Kinase PKR: Implications in Alzheimer's Disease
Anindita Bose et al.
BRAIN PATHOLOGY (2011)
PPAR gamma Co-Activator-1 alpha (PGC-1 alpha) Reduces Amyloid-beta Generation Through a PPAR gamma-Dependent Mechanism
Loukia Katsouri et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Annica Sjolander et al.
MOLECULAR NEURODEGENERATION (2010)
Herba Epimedii: Anti-Oxidative Properties and Its Medical Implications
Stephen Cho Wing Sze et al.
MOLECULES (2010)
Phospho-eIF2α Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD Mice
Latha Devi et al.
PLOS ONE (2010)
Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid-β Load in an Alzheimer's Disease Mouse Model
Daniela Puzzo et al.
JOURNAL OF NEUROSCIENCE (2009)
Phosphorylation of the Translation Initiation Factor eIF2α Increases BACE1 Levels and Promotes Amyloidogenesis
Tracy O'Connor et al.
NEURON (2008)
In vivo β-Secretase 1 inhibition leads to brain Aβ lowering and increased α-secretase processing of amyloid precursor protein without effect on neuregulin-1
Sethu Sankaranarayanan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Share Paper
